Editorji is a popular short video news and information platform based in India. It was founded in 2018 by Vikram Chandra, one of India’s leading journalists, and has risen to prominence in the digital news space in a relatively short span of time. The platform is primarily designed for mobile devices, with applications available for Android and iOS.

ABOUT US:

about us editorji

Latest Video News: Editorji provides the latest news video headlines, latest videos clip from India and the World. Get all breaking news videos on Entertainment, Business, Coronavirus, Elections, Politics and more.

Latest Video News, Breaking News, Bollywood, Political, Sports, Business News | Editorji

+91 11 4035 6666 / info@editorji.com
3rd floor, Plot B, Khasara no 360, Sultanpur, New Delhi, Delhi 110030
<a title="mail to us" href="mailto:info@editorji.com">Send Feedback</a>
<a title="Contact Us" href="mailto:info@editorji.com">Contact Us</a>

REACH US

Contact for any questions, suggestions, comments, feedback or advertisement on Editorji.com, we are always looking forward to hearing from you.

Contact Us for Feedback, Suggestions and Advertising 

Editorji content is better experienced in our app.

Vaccine maker Serum Institute of India (SII) on Friday said the precaution dose of its Covishield vaccine against COVID-19 will be priced at Rs 600 per shot for eligible individuals.
SII CEO Adar Poonawalla also welcomed the government’s move to allow precaution dose of the vaccine to all aged above 18 years at private vaccination centres, saying it will further provide long-term protection against the virus, and aid ease of travel.
“End-users will pay Rs 600 for the booster dose and the hospitals will get at discounted price,” Poonawalla said in a statement.
The Union Health Ministry on Friday announced that those above the age of 18 years who have completed nine months after the administration of the second dose will be eligible for the precaution dose.
Reacting to the government’s decision in a tweet, Poonawalla said, "We are delighted by GOI’s announcement on booster. The decision will further provide long term protection and aid ease of travel." He, however, said the nine-month gap was a bit long although the company had 200 million dosages in stock. SII has the capacity to produce 4 billion dosages.
Poonawalla also exuded confidence that the whole country can be vaccinated in about three months in case of requirement in future.
SII and Bharat Biotech have been major suppliers of COVID-19 vaccines to the government so far.
Earlier in the day, he had stated that the booster dose should be made available to the public, saying it would help in protecting against the virus in future besides helping Indians overcome restrictions while travelling abroad.
In a tweet responding to a user, who highlighted difficulties faced by Indians travelling abroad who got their second dose in April 2021, Poonawalla had said,”I agree with you & sympathise for the inconvenience, boosters now should be made available to the public as a CHOICE.” He further said GoI “has done a fantastic job, protecting our nation with two doses, but in the context of future protection and travel restrictions, boosters will be useful”.
According to the health ministry, so far, about 96 per cent of all those above the age of 15 years in India have received at least one vaccine dose, while about 83 per cent have received both doses.
More than 2.4 crore precaution doses have also been administered to healthcare workers, frontline workers and those aged above 60 years. Besides, 45 per cent of beneficiaries in the 12-14 years age group have received the first dose, the ministry said.
The ongoing free COVID-19 inoculation programme through government vaccination centres for the first and the second dose to the eligible population as well as the precaution dose to healthcare workers, frontline workers and those above 60 years will be accelerated, the ministry stated.

Covishield booster dose priced at Rs 600 per shot: Serum Institute CEO Adar Poonawalla

Reacting to the government’s decision in a tweet, Poonawalla however, said the nine-month gap was a bit long although the company had 200 million dosages in stock

Vaccine maker Serum Institute of India has said the precaution dose of its Covishield vaccine against Covid-19 will be priced at Rs 600 per shot for eligible individuals.
SII CEO Adar Poonawalla also welcomed the government&rsquo;s move to allow precaution dose of the vaccine to all aged above 18 years at private vaccination centres, saying it will further provide long-term protection against the virus, and aid ease of travel.
The Union Health Ministry on Friday announced that those above the age of 18 years who have completed nine months after the administration of the second dose will be eligible for the precaution dose.
Reacting to the government&rsquo;s decision in a tweet, Poonawalla&nbsp;however, said the nine-month gap was a bit long although the company had 200 million dosages in stock. SII has the capacity to produce 4 billion dosages.
Poonawalla also exuded confidence that the whole country can be vaccinated in about three months in case of requirement in future.
SII and Bharat Biotech have been major suppliers of Covid-19 vaccines to the government so far.
&nbsp;

Reacting to the government&rsquo;s decision in a tweet, Poonawalla&nbsp;however, said the nine-month gap was a bit long although the company had 200 million dosages in stock

Vaccine maker Serum Institute of India (SII) on Friday said the precaution dose of its Covishield vaccine against COVID-19 will be priced at Rs 600 per shot for eligible individuals.
<a href="https://www.editorji.com/partner/all-india-management-association/boosting-india-s-health-security-adar-poonawalla-in-conversation-with-sanjiv-goenka-1649847929961" target="_blank">SII CEO Adar Poonawalla</a> also welcomed the government&rsquo;s move to allow precaution dose of the vaccine to all aged above 18 years at private vaccination centres, saying it will further provide long-term protection against the virus, and aid ease of travel.
&ldquo;End-users will pay Rs 600 for the booster dose and the hospitals will get at discounted price,&rdquo; Poonawalla said in a statement.
The Union Health Ministry on Friday announced that those above the age of 18 years who have completed nine months after the administration of the second dose will be eligible for the precaution dose.
Reacting to the government&rsquo;s decision in a tweet, Poonawalla said, "We are delighted by GOI&rsquo;s announcement on booster. The decision will further provide long term protection and aid ease of travel." He, however, said the nine-month gap was a bit long although the company had 200 million dosages in stock. SII has the capacity to produce 4 billion dosages.
Poonawalla also exuded confidence that the whole country can be vaccinated in about three months in case of requirement in future.
WATCH:&nbsp;<a title="Healthy eating: Immunity boosting summer foods to incorporate into your diethttps://www.editorji.com/lifestyle-news/food/healthy-eating-immunity-boosting-summer-foods-to-incorporate-into-your-diet-1647949499634" href="https://www.editorji.com/lifestyle-news/food/healthy-eating-immunity-boosting-summer-foods-to-incorporate-into-your-diet-1647949499634">Healthy eating: Immunity boosting summer foods to incorporate into your diet</a> SII and Bharat Biotech have been major suppliers of COVID-19 vaccines to the government so far.
Earlier in the day, he had stated that the booster dose should be made available to the public, saying it would help in protecting against the virus in future besides helping Indians overcome restrictions while travelling abroad.
In a tweet responding to a user, who highlighted difficulties faced by Indians travelling abroad who got their second dose in April 2021, <a href="https://www.editorji.com/partner/all-india-management-association/boosting-india-s-health-security-adar-poonawalla-in-conversation-with-sanjiv-goenka-1649847929961" target="_blank">Poonawalla </a>had said,&rdquo;I agree with you &amp; sympathise for the inconvenience, boosters now should be made available to the public as a CHOICE.&rdquo; He further said GoI &ldquo;has done a fantastic job, protecting our nation with two doses, but in the context of future protection and travel restrictions, boosters will be useful&rdquo;.
According to the health ministry, so far, about 96 per cent of all those above the age of 15 years in India have received at least one vaccine dose, while about 83 per cent have received both doses.
More than 2.4 crore precaution doses have also been administered to healthcare workers, frontline workers and those aged above 60 years. Besides, 45 per cent of beneficiaries in the 12-14 years age group have received the first dose, the ministry said.
The ongoing free COVID-19 inoculation programme through government vaccination centres for the first and the second dose to the eligible population as well as the precaution dose to healthcare workers, frontline workers and those above 60 years will be accelerated, the ministry stated.

A grave negligence on part of the health workers during the ongoing Covid-19 vaccination has come to the fore in Uttar Pradesh&rsquo;s Siddharth Nagar as&nbsp;Barhni Primary Health Zone in Siddharth Nagar district where around 20 people of Audahi Kalan village were given the first dose of Covishield. However, the same people were given the second dose of Covaxin on May 14 courtesy the callous approach of the health workers.This incident has instilled fear in the people, who have taken both doses of the vaccine.According to the report, people in the local health department began to put the onus on each other for the blunder committed.

UP's villagers receive 1st dose of Covishield & 2nd dose Covaxin, medical officer calls it Cocktail

A grave negligence on part of the health workers during the ongoing Covid-19 vaccination has come to the fore in Uttar Pradesh&rsquo;s Siddharth Nagar as&nbsp;Barhni Primary Health Zone in Siddharth Nagar district where around 20 people of Audahi Kalan village were given the first dose of Covishield. However, the same people were given the second dose of Covaxin on May 14 courtesy the callous approach of the health workers. This incident has instilled fear in the people, who have taken both doses of the vaccine. According to the report, people in the local health department began to put the onus on each other for the blunder committed.

20 villagers get 1st dose of Covishield, 2nd dose Covaxin Incident instilled fear in people who took the vaccines Local health officers blame each other for the blunder&nbsp;

A grave negligence on part of the health workers during the ongoing Covid-19 vaccination has come to the fore in Uttar Pradesh&rsquo;s Siddharth Nagar. At Barhni Primary Health Zone in the district around 20 people of Audahi Kalan village were given the first dose of Covishield. However, the same people were given the second dose of Covaxin on May 14 due to the callous approach of the health workers. This incident has instilled fear in the people, who have taken both doses of the vaccine.

covaccine

Categories